Stevanato Group S.p.A. Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Expenses

Expenses

12 Months Ended

Dec. 31, 2025

Analysis of income and expense [abstract]

9. Expenses

Expenses are detailed as follows:


	For the year ended December 31,
	2025		2024		2023
	(EUR thousand)
Selling and marketing expenses		28,219		24,853		24,978
Research and development expenses		25,436		31,668		35,672
General and administrative expenses		99,664		93,747		88,946
Total Expenses		153,319		150,268		149,596

Selling and marketing expenses are mainly related to personnel expenses for the sales organizations, business development and events costs, travel expenses and other marketing strategic consultancy. They also include net accruals to the provision for bad and doubtful debts for EUR 665 thousand (respectively EUR 65 thousand net accrual in 2024 and EUR 682 thousand net accrual in 2023).

Research and development expenses include costs incurred for research and development activities to support the innovation of our products and components.

General and administrative expenses consist mainly of personnel expenses for administrative functions, consulting fee, directors' compensation, insurance costs (such as Directors & Officers insurance), IT expenses (including software licenses) and rental fees.